Blood test shows high accuracy in detecting stage I non-small cell lung cancer
In a previous study (Goebel et. al, Cancer Genomics Proteomics 16:229-244, 2019), we identified 33 biomarkers for an early stage (I-II) Non-Small Cell Lung Cancer (NSCLC) test with 90% accuracy, 80.3% sensitiv...
20:137
BMC Cancer 2020
No hay comentarios:
Publicar un comentario